Skip to main content
Daily Report

Daily Cosmetic Research Analysis

09/02/2025
3 papers selected
3 analyzed

Three papers stand out today: a blinded multi-centre validation showing LED-based hybrid diffuse reflectance spectroscopy can closely match ISO reference methods for non-invasive SPF/UVA-PF testing; an in-silico modeling framework that accurately predicts SPF and UVA-PF from formulation data, potentially reducing human testing; and a mitochondria-boosted ADSC/DAT hydrogel that enhances angiogenesis and adipose regeneration in vivo as a next-generation soft-tissue filler.

Summary

Three papers stand out today: a blinded multi-centre validation showing LED-based hybrid diffuse reflectance spectroscopy can closely match ISO reference methods for non-invasive SPF/UVA-PF testing; an in-silico modeling framework that accurately predicts SPF and UVA-PF from formulation data, potentially reducing human testing; and a mitochondria-boosted ADSC/DAT hydrogel that enhances angiogenesis and adipose regeneration in vivo as a next-generation soft-tissue filler.

Research Themes

  • Non-invasive sunscreen performance assessment
  • Computational prediction of SPF/UVA-PF
  • Regenerative biomaterials for aesthetic reconstruction

Selected Articles

1. Characterization of LED-based hybrid diffuse reflectance spectroscopy method for determination of SPF and UVA-PF in blinded multi-centre study (ALT-SPF).

78.5Level IIICohort
International journal of cosmetic science · 2025PMID: 40888063

In a blinded multi-centre ring study, LED-based HDRS delivered SPF and UVA-PF estimates with acceptable bias and, after refinement, markedly improved reproducibility and inter-laboratory variability. With just 10 volunteers and bias correction, SPF results were within 11% of the reference reproducibility limit and UVA-PF met acceptance limits in most criteria, indicating precision comparable to ISO 24444/24443.

Impact: This validates a non-invasive alternative to erythema-based SPF testing with near-reference performance, potentially reducing subject risk and accelerating sunscreen development and labeling accuracy.

Clinical Implications: If adopted by regulators, LED-HDRS could limit erythema-based testing, reducing volunteer exposure and enabling more frequent, precise SPF/UVA-PF verification across product lifecycles, improving consumer protection.

Key Findings

  • Blinded multi-centre study on 64 samples (with a 16-sample re-evaluation) showed acceptable bias and improved reproducibility after method refinement.
  • Using n=10 volunteers and bias correction, SPF results were within 11% of the gold-standard reproducibility limit; UVA-PF met acceptance limits except one criterion nearly met.
  • Overall precision was comparable to ISO 24444/24443, supporting LED-HDRS as a viable non-invasive alternative.

Methodological Strengths

  • International blinded round-robin across four laboratories with predefined acceptance criteria and independent statistical assessment.
  • Two-stage evaluation (initial and re-evaluation) demonstrating method improvement and robustness.

Limitations

  • Initial reproducibility and inter-laboratory variability were suboptimal and required method refinement.
  • Small number of volunteers (n=10) in re-evaluation; broader skin types and product categories warrant testing.

Future Directions: Standardize HDRS protocols across devices, expand validation to water resistance and diverse product groups, and pursue regulatory qualification as an alternative to ISO 24444/24443.

OBJECTIVE: The consortium ALT-SPF performed an international round robin test to characterize non-invasive methods as alternatives to the erythema-based testing of sun protection factor (SPF) according to ISO 24444:2019. METHODS: Hybrid diffuse reflectance spectroscopy (HDRS) based on a multi-lambda LED light source uses in vivo reflectance spectra on skin to determine sunscreens in vivo absorbance spectra, which are fused with respective in vitro absorbance spectra measured as thin films transmission as described in ISO 24443:2019. As a part of the ALT-SPF consortium initiative, a blinded study on 64 samples was performed in four European laboratories. After further improvements of the method, a blinded re-evaluation based on 16 samples was performed. Five statistical acceptance criteria for new methods were assessed by an independent statistical institute to compare the obtained results to the reference methods for SPF and UVA-PF. RESULTS: The initial ALT-SPF study 1 showed that the bias criterion was acceptable, while the reproducibility and interlaboratory variability needed further improvement. The re-evaluation study 2 showed that the reproducibility and interlaboratory variability could be considerably improved. Using only n = 10 volunteers and a bias correction based on the initial ALT-SPF study 1 data, the SPF results of the re-evaluation study 2 were close to the acceptance criteria of the ALT-SPF study with criterion 1 (reproducibility) and only 11% over the limit defined by the performance of the gold standard. The UVA-PF results were within the acceptance limits for the acceptance criteria, except criterion 3 being in the 'almost met' range. The re-evaluation study indicates that the method has a comparable precision to the gold standard methods ISO 24444 and ISO 24443. CONCLUSION: This study showed that the LED-HDRS method is capable of providing reasonable non-invasive SPF and UVA-PF results and that the performance shows close alignment to the reference method. Thus, it can be proposed as an alternative method to the current standards ISO 24444 and ISO 24443.

2. The ALT-SPF ring study-Correlation in silico versus in vivo SPF ISO24444 and in vitro UVA-PF ISO24443.

76Level IVCase series
International journal of cosmetic science · 2025PMID: 40888055

An in-silico framework predicted SPF and UVA-PF by combining quantified UV filter profiles, photostability/interaction parameters, phase synergies, and film thickness distribution, reproducing ISO 24444/24443 outcomes across 32 formulations. Predictions tended to align with lower in vivo SPF values, favoring consumer safety, and could reduce the need for invasive or extensive laboratory testing.

Impact: Accurate computational SPF/UVA-PF prediction represents a major step toward reducing human testing, accelerating formulation optimization, and enabling safety-by-design in photoprotection.

Clinical Implications: More reliable, conservative SPF predictions can improve labeling accuracy and consumer counseling while minimizing the number of volunteers exposed to erythema-inducing tests.

Key Findings

  • In-silico SPF and UVA-PF predictions closely correlated with ISO 24444/24443 across 32 tested formulations.
  • Model integrates quantitative UV-filter absorbance, photodegradation/interactions, oil/water synergies, and non-uniform film thickness distribution.
  • Predictions align with the lower bound of in vivo SPF values, enhancing consumer safety and potentially reducing human testing needs.

Methodological Strengths

  • Defined statistical benchmarks for correlation to ISO standards and a curated set of 32 blinded formulations.
  • Analytical deconvolution of filter concentrations and properties feeding a mechanistically grounded computational model.

Limitations

  • Accuracy depends on precise input data (filter identity, concentration, photodegradation/interaction parameters).
  • Validation dataset limited to ring-test products; broader chemistries and conditions (e.g., water resistance) require testing.

Future Directions: Expand databases of filter properties, incorporate formulation microstructure effects, validate across diverse product groups and photostability scenarios, and pursue regulatory acceptance.

This paper presents the results of the Alt-SPF consortium ring test, obtained by the in-silico methodology, and discusses these results in the context of existing standards. To evaluate the effectiveness of the in-silico methodology in correlating with these standards, a comparison was made between the in-silico sun protection factor (SPF) and the UVA protection factor (UVA-PF) and the values derived by standard in vivo SPF (ISO24444) and in vitro UVA-PF (ISO24443). The model utilises the same algorithm as in vitro measurements of SPF and UVA-PF, with the measured UV transmission substituted by calculated transmission simulated through an applied sunscreen film. The in-silico approach necessitates quantitative UV absorbance data of all UV-filters, their photodegradation and photointeraction properties, oil/water phase synergies and a model describing the irregular distribution of the film thickness on the skin. The performance factors are calculated using an initial analytical evaluation of the 32 test formulations of the ring test, to ascertain the presence and concentration of individual UV absorbers. The filter concentrations obtained are then processed via computational analysis to calculate the SPF and UV-PF values. It has been demonstrated that, in accordance with defined statistical parameters to characterize the ability of a method to correlate with the in vivo SPF standard, the in-silico methodology is a highly reproducible and accurate tool for SPF prediction. The alignment with the lowest measured in vivo SPF values serves to ensure the safety of the end consumer and is not a weakness of the method. Additionally, it has been demonstrated that the methodology facilitates precise prediction of UVA protection in comparison to the in vitro standard ISO 24443. These calculations can be employed to engineer novel sunscreens, thereby diminishing the necessity for ethically questionable and extensive laboratory measurements. In case still in-vivo measurements are needed, the methodology can deliver the frequently required SPF/UVA-PF values and may also support functions such as those of responsible persons, including safety assessors, in their evaluations.

3. Mitochondria transplanted adipose-derived stem cells/decellularized adipose tissue hydrogel for adipose tissue regeneration.

73Level VCase series
Materials today. Bio · 2025PMID: 40893355

A mitochondria-transplanted ADSC/DAT hydrogel enhanced angiogenesis and adipose regeneration in a nude mouse model. Mechanistically, Mito-ADSCs showed increased maximal respiration, spare respiratory capacity, glycolysis, and pro-angiogenic capacity without a significant increase in adipogenic differentiation in vitro, suggesting metabolic reprogramming underlies improved tissue regeneration.

Impact: This introduces a metabolically enhanced, cell-based soft-tissue filler with in vivo efficacy, addressing limitations of fat grafting and synthetic fillers and opening a path to durable aesthetic reconstruction.

Clinical Implications: If safety and durability are confirmed in humans, Mito-ADSC/DAT hydrogels could offer longer-lasting, vascularized soft-tissue augmentation for cosmetic and reconstructive indications compared with current fillers or fat grafts.

Key Findings

  • Mito-ADSCs/DAT hydrogel improved angiogenesis and adipose tissue regeneration in a nude mouse subcutaneous injection model.
  • Mito-ADSCs displayed increased maximal respiration, spare respiratory capacity, and glycolysis, with enhanced pro-angiogenic activity by in vitro assays and RNA-seq.
  • No significant enhancement of adipogenic differentiation in vitro, indicating metabolic reprogramming rather than direct adipogenesis drives in vivo benefits.

Methodological Strengths

  • Combined in vivo efficacy testing with in vitro functional assays and transcriptomic (RNA-seq) analysis.
  • Clear mechanistic linkage between mitochondrial enhancement and pro-angiogenic/metabolic phenotypes.

Limitations

  • Preclinical study without human data; long-term safety (e.g., ectopic tissue formation, immunogenicity) remains unknown.
  • Standardization of mitochondrial transfer, dosing, and GMP manufacturing not addressed.

Future Directions: Evaluate safety, durability, and integration in large-animal models; optimize dosing and manufacturing; proceed to early-phase clinical trials for facial and soft-tissue reconstruction.

Adipose tissue reconstruction is of significant importance for both cosmetic procedures and therapeutic interventions. Current clinical strategies, including autologous adipose tissue grafting and the application of synthetic materials, still have limitations. Decellularized adipose tissue (DAT) hydrogel in combination with adipose-derived stem cells (ADSCs), has emerged as a superior alternative, because of the abundant sources and inherent adipose regeneration capacity. Nevertheless, the therapeutic potential is constrained by the suboptimal functionality of ADSCs, due to the donor health status, long-term culture, and the post-transplantation environment in vivo. Mitochondria transplantation can enhance the proliferation, migration, differentiation, and pro-angiogenic ability of mesenchymal stem cells, thereby improving the tissue regeneration outcomes. In our research, we developed a novel soft tissue filler, mitochondria transplanted adipose-derived stem cells/decellularized adipose tissue (Mito-ADSCs/DAT) hydrogel. The constructive influence of the Mito-ADSCs/DAT hydrogel to angiogenesis and adipose tissue regeneration was validated in the nude mouse subcutaneous injection model. In vitro experiments and RNA-seq analysis were employed to elucidate the mechanism of Mito-ADSCs in improving adipose tissue regeneration. Although no significant enhancement in adipogenic differentiation was observed in vitro, the Mito-ADSCs exhibited promoted maximal respiration and spare respiratory capacity, and the glycolysis metabolism in Mito-ADSCs increased. Moreover, Mito-ADSCs demonstrated a marked increase in pro-angiogenic capability, which was corroborated by both in vitro assays and RNA-seq analysis. In general, our research demonstrated that the Mito-ADSCs/DAT hydrogel achieved ideal results in adipose tissue regeneration, emerging as a promising soft tissue filler for adipose tissue reconstruction and warranting further investigation for clinical translation.